If you guys had read the circular, it did mention that they are finalising two construction projects worth RM163 million by 15 March. Just wait for them to pump up the price. Especially after the Special issue is completed.
Kstar at 11cts looks attractive esp with the internal organisation of the company to be completed soon, private placement and transfer of listing under new name..
Khairy Jamaluddin, head of the Covid-19 Immunisation Task Force (CITF), speaks at a press conference on February 17, 2021. Picture from Twitter @RembauForever.
KUALA LUMPUR, March 10 — Vaccine Minister Khairy Jamaluddin today encouraged the private sector to procure Covid-19 vaccines approved by local pharmaceutical regulators, paving the way for a potential parallel vaccine rollout by private health care providers.
Khairy was responding to a statement on Facebook by former Prime Minister Najib Razak, who asked the government to state clearly if private clinics and hospitals are able to purchase their own supply of Covid-19 vaccines, as currently there is mixed information on the involvement of private health care providers in the inoculation drive.
Najib pointed out that on March 6, Science, Technology, and Innovation Deputy Minister Ahmad Amzad Hashim said that although there were requests from the private sector to purchase Covid-19 vaccines through the government, the priority for the government is still to get adequate supply of vaccines for 80 per cent of the population.
“With regards to the purchase of vaccines by the private sector, as I have mentioned yesterday, most of the vaccine manufacturers only carry out negotiations with governments,” Khairy responded to Najib in a comment on his Facebook post.
“If Dato’ Sri still doesn’t want to believe, I cannot do anything, I leave it up to Dato’ Sri.
“But if there are private parties who are able to carry out negotiations with vaccine manufacturers, especially those that have received approval from the NPRA (National Pharmaceutical Regulatory Agency) (Pfizer, AstraZeneca, and Sinovac), please do so. I really welcome it,” added the science, technology and innovation minister.
Previously, Malaysian-based pharmaceutical company Pharmaniaga Bhd announced that it planned to sell some of its Sinovac vaccine doses to the private sector. Pharmaniaga is undertaking the fill-and-finish processing of Sinovac’s vaccine.
Solution Biologics, the distributor of Chinese CanSino’s vaccine, has also expressed plans to supply private health care providers with the vaccine, on top of selling 3.5 million doses to the Malaysian government.
Private hospitals have previously urged the government to allow a parallel private Covid-19 vaccine rollout, with doses independently procured by private facilities, in order to expedite Malaysia’s vaccination coverage. As such, private health care providers have urged NPRA to quickly approve other Covid-19 vaccines authorised in other countries, such as Moderna.
Khairy highlighted today that Malaysia targets to achieve herd immunity by February 2022, as mentioned in the National Covid-19 Immunisation Programme (PICK) guideline.
He said that during the second and third phase of PICK, since the target number of daily doses administered will have to be raised up to 160,000, the Ministry of Health will increase the number of vaccinators to 7,000.
“With 7,000, we are able to achieve a number of more than 160,000. But we don’t want to over-promise as we are aware that vaccine supply will be sent over in stages,” Khairy told Najib.
As Najib has raised multiple issues on the Covid-19 vaccine rollout several times on his Facebook page, Khairy invited Najib to a briefing on PICK, along with all other
Report by The New York Times on Feb 5, 2021. In the safety ranking, the top four are all Chinese vaccines: 1. Sinopharm (China) 2. Sinopharm (China) 3. Kexing (China) 4. Can Sino (China) 5. AstraZeneca (UK) 6. Pfizer (United States and Germany) 7. Modena (United States) 8. Johnson & Johnson (United States) 9. Novavax (United States) 10. Satellite 5 (Russia) Sinopharm has two vaccines, ranking first and second respectively. China has exported more than 500 million doses of vaccines to more than 50 countries around the world, and it is estimated that hundreds of millions of people have been vaccinated. And China's vaccine accident rate is lower and safer. As reported by Western media, many wealthy people in Britain fly to the UAE to vaccinate Chinese national medicine. 《纽约时报》 2021年2月5日的报道。 在安全性排名中,排名前四的都是中国疫苗: 1.国药(中国) 2.国药(中国) 3.克星(中国) 4.信诺(中国) 5.阿斯利康(英国) 6.辉瑞(美国和德国) 7.摩德纳(美国) 8.强生(美国) 9. Novavax(美国) 10.卫星5(俄罗斯) 国药有两种疫苗,分别排名第一和第二。 中国已经向全球50多个国家出口了超过5亿剂疫苗,据估计已有数亿人接种了疫苗。 而且中国的疫苗事故率更低,更安全。 据西方媒体报道,英国许多有钱人飞往阿联酋为中药注射疫苗。
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
Flyinghorse
3,705 posts
Posted by Flyinghorse > 2021-02-16 16:58 | Report Abuse
Massive dumping at 0.115.